Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.93% | 240.93 | 1.3% | $857.67m | |
| MRNA | Moderna, Inc. | -2.18% | 67.75 | 0.0% | $761.08m | |
| NVAX | Novavax, Inc. | -2.57% | 107.32 | 96.5% | $689.21m | |
| IMMU | Immunomedics, Inc. | -0.13% | 85.30 | 11.0% | $663.23m | |
| GILD | Gilead Sciences, Inc. | -1.31% | 63.37 | 1.0% | $581.92m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 555.72 | 2.7% | $450.22m | |
| ILMN | Illumina, Inc. | -1.62% | 265.76 | 3.5% | $381.22m | |
| BIIB | Biogen, Inc. | -0.22% | 267.72 | 1.6% | $335.30m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.32% | 260.51 | 1.9% | $325.73m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.10% | 111.63 | 2.0% | $276.12m | |
| SRNE | Sorrento Therapeutics, Inc. | -4.05% | 9.36 | 1.5% | $266.58m | |
| VXRT | Vaxart, Inc. | -4.56% | 8.58 | 0.0% | $245.26m | |
| MNTA | Momenta Pharmaceuticals, Inc. | -0.02% | 52.36 | 3.0% | $213.07m | |
| SGEN | Seattle Genetics, Inc. | -0.46% | 178.01 | 6.0% | $202.90m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.87% | 75.84 | 4.3% | $198.13m |
Company Profile
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.